Helix BioPharma Corp. (HBPCF)
OTCMKTS · Delayed Price · Currency is USD
1.734
+1.134 (189.00%)
At close: Oct 22, 2025
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of $118.05 million as of January 16, 2026. Its market cap has increased by 153.25% in one year.
Market Cap
118.05M
Enterprise Value
117.94M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.73
Market Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 118.05M, an increase of 1,611.79%. That is a compound annual growth rate of 9.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 118.05M | -10.59% |
| Dec 31, 2025 | 132.02M | 335.39% |
| Dec 31, 2024 | 30.32M | -11.99% |
| Dec 29, 2023 | 34.45M | 8.43% |
| Dec 30, 2022 | 31.77M | -5.92% |
| Dec 31, 2021 | 33.77M | -36.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |